1996
DOI: 10.1007/s002280050047
|View full text |Cite
|
Sign up to set email alerts
|

Cough due to ace inhibitors: a case-control study using automated general practice data

Abstract: The risk of coughing was increased twofold among ACE inhibitor users, but the odds ratios were no longer significant after controlling for several confounding factors. The risk of developing cough due to ACE-inhibitors declines with the duration of treatment, possibly due to depletion of susceptible persons.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

1999
1999
2006
2006

Publication Types

Select...
3
1

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…The prior evidence of this association was based on a large number of case reports and two large studies based on GP data. The IPCI database has been used to study the association between ACE inhibitors and cough [7]. The source population for this study was patients from 10 general practices in the period 1 September 1992 to 1 March 1994.…”
Section: Validationmentioning
confidence: 99%
“…The prior evidence of this association was based on a large number of case reports and two large studies based on GP data. The IPCI database has been used to study the association between ACE inhibitors and cough [7]. The source population for this study was patients from 10 general practices in the period 1 September 1992 to 1 March 1994.…”
Section: Validationmentioning
confidence: 99%
“…To test the quality of the data in the IPCI database, three epidemiological studies were performed to confirm well-known adverse reactions to drugs: the association between the use of ACE-inhibitors and cough (18), antibiotics and skin reactions (19), and fluoroquinolones and tendinitis (20). All these validation studies were able to confirm the positive associations that had been reported previously.…”
Section: Post-marketing Surveillancementioning
confidence: 92%
“…Applied to the drug-safety system, the inputsystem of the central database can not be validated, because it is a fully automated process. The PMS-module is validated by a group of GPs and the database system including research tools by a scientific researcher (Visser, Vlug, Van der Lei and Stricker, 1996). The whole system including the protocols of anonymization, encryption and the role of the Supervisory Board is validated by the participating doctors.…”
Section: Hard Systems Methodology: Concepts and Methodsmentioning
confidence: 99%